Buscar

Breast cancer screening has long been a cornerstone of women's healthcare. With 1 in 8 women diagnosed with breast cancer in their lifetime1, the United States Preventive Services Task Force (USPSTF) has developed screening recommendations to help detect early-stage cancer. Notably in 2023, the USPSTF revised the recommended age for biennial mammogram screenings for women with average risk to start at age 40 instead of 502, estimated to result in 19% more lives being saved3 by starting screening earlier. While initiating screening at an earlier age offers advantages to a wide demographic, concerns about the potential of over-screening prompted research into the feasibility of identifying women with lower breast cancer risk who could safely delay mammograms. While guidelines address high-risk individuals, a notable gap exists in providing recommendations tailored to those at lower risk. To gain insight into a patient's risk level, physicians are able to utilize genetic testing to understand an individual's genetic makeup, providing precise insights into their predisposition to various health conditions, including breast cancer. Armed with this genetic information, healthcare providers could craft tailored screening strategies that align with an individual’s specific risk profile. This genetic risk-based approach underscores the value of genetics in individualizing the onset of screening to help avoid over-screening and its associated costs. Surprisingly, genetic information is not currently being widely utilized to identify women at risk of breast cancer or other diseases in clinical practice, despite its potential to make a significant positive impact for patients. A recent retrospective analysis of 25,591 women from the Healthy Nevada Project4 sheds light on the potential benefits of this genetic risk-based approach. The study classified 2,338 (9.1%) of these women as having a low genetic risk for breast cancer. What's remarkable is that these women exhibited a significantly lower and later onset of breast cancer compared to their average or high-risk counterparts. This finding suggests that it might be safe for low-risk women to delay mammogram screening by 5 to 10 years without compromising their health.

Read More About Optimizing Mammogram Screenings: A Genetic Approach to a Personalized Screening Schedule

Did you know that 218,000 veterans and their families call Nevada home? That is almost 7% of our total population who served this country and will require quality access to healthcare at some point in their lifetime.  When faced with a daunting diagnosis or procedure, such as cancer or surgery, Renown rises to the occasion to provide veterans and their loved ones with the highest caliber of care possible to protect the lives that protected ours.  Accessing that care, however, can be a challenge for some. As Renown serves veterans across 100,000 square miles, veterans living in rural communities often must travel long distances – with the costs of overnight lodging standing in the way, making healthcare access out-of-budget, and sometimes, nearly impossible.  That’s where Veterans Guest House comes in. Veterans Guest House provides veterans and their families with temporary overnight accommodations while receiving medical treatment in the Reno/Sparks area. Founded in 1993 in response to the growing number of veterans sleeping in their cars to access healthcare, the nonprofit embraces veterans and their families who would otherwise not be able to obtain the medical care they need because of inabilities to pay for overnight lodging.  A support system for veterans, especially veterans who are senior citizens, is vital to their overall health and well-being – and seniors at Veterans Guest House never have to feel alone in their care journey.  Enter Dyana Parks, a senior care assistant working with Veterans Guest House. A friend to Renown Health and the William N. Pennington Cancer Institute, Dyana goes the extra mile for seniors staying at Veterans Guest House – she not only helps them navigate the logistics of their care, but she also is one of their biggest mental well-being champions.  A Helping Hand for Guests in Need  A proud member of a veteran family herself, senior and veteran in-home care is a family affair for Dyana. With a sister experiencing post-accident brain damage, elderly parents – one of whom facing dementia – and a son and daughter-in-law in the same field of work, Dyana has a unique passion for in-home and dementia care and holds several decades of hospice experience. As such, when she was assigned to help the clients at Veterans Guest House in September 2022, it was a natural fit for her, and she immediately jumped into action.  Dyana takes special time during her work hours to transport seniors in need to their appointments at Renown (and keeps track of all of them), sits with them through chemotherapy and radiation treatments, ensures patients stay hydrated and nourished after major procedures, picks them up from surgery and always ensures everything goes well with each patient’s care. When patients coming from Veterans Guest House need extra emotional support, Dyana is always there to make sure they are okay and push them to keep going.  “I always say to my seniors, ‘never give up,’” said Dyana. “If a need arises, I am there to help. I love getting to know my clients and helping them go home healthy.”  As a ‘frequent flier’ at Renown and the William N. Pennington Cancer Institute, many of our team members are thrilled when they see Dyana walking through the doors with her clients, as they know that their patient is going home with one of their strongest advocates. To Dyana, Renown is akin to a family for both herself and her clients.  “I love Renown,” said Dyana. “Everyone there makes my clients feel as though they are more than just a patient – they make them feel like family, especially when going through a scary diagnosis like cancer. As someone who has been going there with my own family forever and who now guides veteran seniors through the process, I will always recommend Renown to anyone.”  Dyana emulates exactly what it means to make a genuine difference in the health and well-being of our community, all while raising awareness for both Renown and Veterans Guest House.  “More people need to know about Veterans Guest House,” said Dyana. “When I came here, I was in awe. They do so much for every guest, making them feel comfortable at home while not having to worry about finances. Almost everyone that comes here, whether it be from the rural surrounding towns or all the way out to Alaska and even the Philippines, needs treatment of some kind, and I know Renown will always give them the best care.”  To learn more about Veterans Guest House, visit veteransguesthouse.org.

Read More About A Friend to Veterans, A Friend to Renown

While there used to be three basic treatment options for cancer -- surgery, radiation and chemotherapy, or a combination of the three -- there's a fourth option: clinical trials. Here, a Renown patient shares her successful battle with ovarian cancer, aided by a clinical trial. Shari Flamm's battle with ovarian cancer began in 2011. She was experiencing prolonged bleeding, irregular thyroid levels and anemia and was scheduled to undergo a hysterectomy. Before the surgery, her gynecologist ran routine tests to check for cancer as a precautionary measure. All tests were negative for cancer, expect her CA 125 test. A CA 125 test measures the amount of the protein CA 125 (cancer antigen 125) in the blood. In some cases, a CA 125 test may be used to look for early signs of ovarian cancer in women with a very high risk of the disease. In most laboratories, the normal level is 0 to 35 units/ml. Flamm's CA 125 level was 121. As Flamm can attest, early diagnosis played a key role in her battle with ovarian cancer. September is Gynecologic Cancer and Ovarian Cancer Awareness Month – an important time to learn the signs, symptoms and risk factors of this type of cancer so your doctor can diagnosis the disease as early as possible. Ovarian Cancer: Round One Despite the elevated CA 125 results, her doctor recommended they move forward with the hysterectomy. But when surgery began, doctors discovered a mass. She had stage 4 cancer. The procedure was halted, the mass was biopsied and she was immediately seen by Dr. Peter Lim of the The Center of Hope. Following diagnosis, Flamm underwent surgery with Dr. Lim to remove the cancer, which had spread to part of diaphragm, spleen, colon and other organs. Three months after surgery, Flamm had recovered enough to start six rounds of chemotherapy in her hometown of Carson City. She continued working at a doctor's office during her treatment, and was grateful for Dr. Lim’s ability to co-manage her care so she could stay close to work and family. “To me, chemo was the scariest part because I didn’t like feeling sick,” Flamm says. Thankfully, her body responded well to the treatments and she was back to the things she loved. “I stated working out at the gym, even if it was only for 10 minutes,” she says. She also stayed positive by spending time with her grandchildren, attending a San Jose Sharks hockey game, going for walks and enjoying concerts. Ovarian Cancer: Round Two In November 2014, Flamm had a cancer check-up. That’s when doctors discovered three cancerous tumors. For this round, Flamm choose another treatment option -- clinical trials at Renown Institute for Cancer. Clinical trials are the studies that test whether drugs work, and inform doctors' decisions about how to treat their patients. Flamm participated in a clinical trial that featured oral-targeted therapy stronger than IV chemotherapy. The hope was for the drug to shrink her tumors, however the result was stabilization -- meaning the lumps weren’t growing or spreading. The best part of the clinical trial, Flamm says, was the constant monitoring. Between the CT scans every six weeks, a heart scan every three months and monthly doctor visits, she was confident that if the cancer started growing or spreading, her healthcare team would catch it right away. For Flamm, the benefits of the clinical trial included less hair loss, less fatigue and more time to focus on what’s important in her life -- her family. “I decided I wasn’t going to be that sick grandma on the couch with cancer,” Flamm says. After taking the oral medication for one year, Flamm developed a rash and discontinued treatment due to discomfort. Clinical Trials, Setbacks and Survival In June 2016, two of the three tumors began to grow and had to be surgically removed. Despite the setback, Flamm was determined to maintain a positive outlook. "You have to stay positive because cancer feeds off anger, depression and stress," Flamm says. Flamm was released to go home with clear margins, meaning the tumors were removed and are surrounded by a rim of normal tissue that does not have cancerous cells. Flamm says her outlook on life has changed drastically since her first cancer diagnosis. “Your whole mentality changes when cancer disturbs your life," Flann says. "The things that weren’t important, are now ever so important. I’m a lot calmer now,” Flamm says.

Read More About Ovarian Cancer Survivor Shares Decision to Try Clinical Trial